Evidence map›Paper›PMID 24809827›Full record

ArticlePloS one2014

Visual function assessment in simulated real-life situations in HIV-infected subjects.

Giulio Barteselli, Jay Chhablani, Maria Laura Gomez, Aubrey L Doede, Laurie Dustin, Igor Kozak, Dirk-Uwe Bartsch, Stanley P Azen, Scott L Letendre, William R Freeman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Giulio BarteselliDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Center, University of California San Diego, La Jolla, California, United States of America; Ophthalmological Unit, Department of Clinical Sciences and Community Health, Ca' Granda Foundation-Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Jay ChhablaniDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Center, University of California San Diego, La Jolla, California, United States of America; Srimati Kanuri Santhamma Vitreo-Retina Service, L.V. Prasad Eye Institute, Hyderabad, India.
Maria Laura GomezDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Center, University of California San Diego, La Jolla, California, United States of America.
Aubrey L DoedeDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Center, University of California San Diego, La Jolla, California, United States of America.
Laurie DustinDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Igor KozakDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Center, University of California San Diego, La Jolla, California, United States of America; King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
Dirk-Uwe BartschDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Center, University of California San Diego, La Jolla, California, United States of America.
Stanley P AzenDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Scott L LetendreHIV Neurobehavioral Research Center, University of California San Diego, La Jolla, California, United States of America.
William R FreemanDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Center, University of California San Diego, La Jolla, California, United States of America.
University of California, San Diego · USUniversity of Southern California · USFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITKing Khaled Eye Specialist Hospital · SAL V Prasad Eye Institute · INNeurobehavioral Research (United States) · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAVID J MOORE · 2001 to 2026
$50.4M
Vision BiostatisticsP30EY022589 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Derek Stuart Welsbie · 2012 to 2026
$10.3M
TREATMENT OF RETINOPATHY ASSOCIATED WITH AIDSR01EY007366 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FREEMAN, WILLIAM R. · 1988 to 2013
$7.6M
Mechanistic-Based Non-Invasive Assessment of Retinal Damage in HAART EraR01EY016323 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BARTSCH, DIRK-UWE G · 2006 to 2020
$5.0M
Crystalline Antiproliferative Drugs for Intraocular DiseasesR01EY018589 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FREEMAN, WILLIAM R. · 2008 to 2011
$2.0M
Midcareer Investigator Award in Patient-Oriented NeuroAIDS ResearchK24MH097673 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LETENDRE, SCOTT L · 2013 to 2017
$917k
NEI NIH HHS P30 EY022589NEI NIH HHS R01 EY007366NEI NIH HHS R01EY007366NEI NIH HHS R01 EY016323NEI NIH HHS R01EY016323NEI NIH HHS R01 EY018589NEI NIH HHS R01EY018589NIMH NIH HHS K24 MH097673NIMH NIH HHS P30 MH062512
6 · The paper itself

Abstract

Visual function abnormalities are common in people living with HIV disease (PLWH) without retinitis, even after improvement in immune status. Abnormalities such as reduced contrast sensitivity, altered color vision, peripheral visual field loss, and electrophysiological changes are related to a combination of retinal dysfunctions, involving inner and outer retinal structures. The standard protocol for testing vision performance in clinical practice is the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. However, this method poorly correlates with activities of daily living that require patients to assess visual stimuli in multiple light/contrast conditions, and with limited time. We utilized a novel interactive computer program (Central Vision Analyzer) to analyze vision performance in PLWH under a variety of light/contrast conditions that simulate stressful and real-world environments. The program tests vision in a time-dependent way that we believe better correlates with daily living activities than the non-timed ETDRS chart. We also aimed to correlate visual scores with retinal neuro-fiber layer thickness on optical coherence tomography. Here we show that visual acuity is more affected in PLWH in comparison to HIV-seronegative controls in varying contrast and luminance, especially if the nadir CD4+ T-cell count was lower than 100 cells/mm3. Visual impairment reflects the loss of retinal nerve fiber layer thickness especially of the temporal-inferior sector. In PLWH the ETDRS chart test led to better visual acuity compared to the Central Vision Analyzer equivalent test, likely because patients had indefinite time to guess the letters. This study confirms and strengthens the finding that visual function is affected in PLWH even in absence of retinitis, since we found that the HIV serostatus is the best predictor of visual loss. The Central Vision Analyzer may be useful in the diagnosis of subclinical HIV-associated visual loss in multiple light/contrast conditions, and may offer better understanding of this entity called "neuroretinal disorder".

Indexed as

Vision TestsAdultAgedAged, 80 and overContrast SensitivityFemaleHIV InfectionsHumansLightMaleMiddle AgedTomography, Optical Coherence

Identifiers

PMID24809827
PMCPMC4014600
OpenAlexW2036711557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.